Skip to main content

Obsessive-Compulsive Disorder clinical trials at UC Health
4 in progress, 1 open to new patients

  • BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder

    open to eligible people ages 18-65

    The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Obsessive Compulsive Disorder (OCD).

    at UCSD

  • Initial Development and Dissemination of OC-Go

    Sorry, accepting new patients by invitation only

    The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pediatric OCD treatment programs in the UCLA Division of Child and Adolescent Psychiatry

    at UCLA

  • Randomized Controlled Trial of Standard ERP and OC-Go

    Sorry, not yet accepting patients

    Phase II of this study will examine the efficacy of the OC-Go application via a randomized controlled trial comparing standard exposure and response prevention (ERP) treatment for pediatric obsessive compulsive disorder (OCD) to exposure/response prevention (ERP) augmented with OC-Go. A cross-over design will be implemented for these 12 sessions of treatment, in which participants that were randomized to standard ERP will receive OC-Go augmented ERP for the second half of treatment, and vice versa. Efficacy will be investigated in a sample of 32 children with OCD.

    at UCLA

  • Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

    Sorry, in progress, not accepting new patients

    To evaluate the long-term impact of treatment with sertraline on aspects of cognitive, emotional and physical development and pubertal maturation in pediatric subjects ages 6 to 16 years (inclusive) with a diagnosis of anxiety disorder, depressive disorder or obsessive compulsive disorder.

    at UCLA

Last updated: